Gallois, Yves

Publishing since 1989 (Dinosaur)

Has published 35 publications in 21 years

Number of publications published per year by Gallois, Yves. (Source : PubMed)

Distribution of publications types for Gallois, Yves. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N, Rousselet MC, Konaté A, Amrani N, de Ledinghen V, Calès P. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.  Liver Int.  2009;29;10  
•  Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P. Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.  Diabetes  2009;58;11  
•  Fizanne L, Régenet N, Wang J, Oberti F, Moal F, Roux J, Gallois Y, Michalak S, Calès P. Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.  Hepatology international  2008;2;4  
•  Calès P, Boursier J, Oberti F, Hubert I, Gallois Y, Rousselet MC, Dib N, Moal V, Macchi L, Chevailler A, Michalak S, Hunault G, Chaigneau J, Sawadogo A, Lunel F. FibroMeters: a family of blood tests for liver fibrosis.  Gastroenterol. Clin. Biol.  2008;32;6 Suppl 1  
•  Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, Travert F, Abi Khalil C, Miot A, Alhenc-Gelas F, Lievre M, Marre M. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.  Diabetes Care  2008;31;9  
•  Gaudin-Audrain C, Gallois Y, Pascaretti-Grizon F, Hubert L, Massin P, Baslé MF, Chappard D. Osteopontin is histochemically detected by the AgNOR acid-silver staining.  Histol. Histopathol.  2008;23;4  
•  Illouz F, Roulier V, Rod A, Gallois Y, Pellé CP, Aubé C, Rohmer V, Ritz P, Ducluzeau PH. Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome.  Diabetes Metab.  2008;34;1  
•  Aubé C, Moal F, Oberti F, Roux J, Croquet V, Gallois Y, Argaud C, Caron C, Calès P. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats.  Dig. Dis. Sci.  2007;52;10  
•  Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.  World J. Gastroenterol.  2006;12;41  
•  Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis.  Hepatology  2005;42;6  

[ See timeline ] [ See all publications ]